Cancer site | Number | Per cent |
---|---|---|
C22—liver and intrahepatic bile ducts | 2 | 1.14 |
C34—bronchus and lung | 2 | 1.14 |
C41—bone and articular cartilage of other and unspecified sites | 10 | 5.68 |
C49—other connective and soft tissue | 7 | 3.98 |
C52—vagina | 5 | 2.84 |
C56—ovary | 3 | 1.70 |
C62—testis | 12 | 6.82 |
C64—kidney except renal pelvis | 7 | 3.98 |
C69—eye and adnexa | 6 | 3.41 |
C71—brain | 27 | 15.34 |
C72—spinal cord, cranial nerves, other CNS | 3 | 1.70 |
C74—adrenal gland | 6 | 3.41 |
C75—other endocrine glands and related structures | 4 | 2.27 |
C76—other and ill-defined sites | 2 | 1.14 |
C83—diffuse non-Hodgkin's lymphoma | 3 | 1.70 |
C85—other and unspecified non-Hodgkin's | 2 | 1.14 |
C91—lymphoid leukaemia | 37 | 21.02 |
C92—myeloid leukaemia | 10 | 5.68 |
C94—other leukaemias of specified cell type | 2 | 1.14 |
D32—meninges | 3 | 1.70 |
D40—Uncertain/unknown behaviour male genital | 2 | 1.14 |
D43—uncertain/unknown behaviour brain and CNS | 2 | 1.14 |
D44—uncertain/unknown behaviour Endocrine | 1 | 0.57 |
D47—uncertain/unknown behaviour of lymphoid, haematopoietic and related tissue | 9 | 5.11 |
D48—uncertain/unknown behaviour unknown sites | 9 | 5.11 |
CNS, central nervous system.